Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial

Research in context Evidence before this study Evidence before this study Amblyopia is the most common childhood visual disease, affecting 1–5% of the global population. If left untreated, amblyopia can lead to life-long serious visual impairment as well as lead to negative experiences for children receiving treatment (eg, bullying), which can affect children psychologically and socially at the time of treatment and even later in life.